Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Mitomycin C in Pterygium Surgery
NCT01115517Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Oct 2010
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised trial of bevacizumab in pterygium (2 arms), sponsored by UTHealth Houston. Primary endpoint: Number of Participants Who Had Recurrence of Pterygia at 1 year. Started Oct 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT01115517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01115517.